Imagion Biosystems Reports Progress on Regulatory Pathway
April 4, 2018
MELBOURNE, Australia, April 4, 2018 /PRNewswire/ — Imagion Biosystems Limited (ASX:IBX), a company dedicated to improving healthcare through the earlier detection of cancer, is pleased to